FDA Should Regulate Biologic Generics: FTC Report
Giving the U.S. Food and Drug Administration the authority to approve generic versions of biologic drugs would be an effective way to cut costs for the pricey treatments and introduce competition...To view the full article, register now.
Already a subscriber? Click here to view full article